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Background: Measles is a signiﬁcant public health problem in
Indiaandmanyotherdevelopingcountries.A singledoseofmeasles
vaccine is administered at 9 months of age, assuming that infants
are protected by transplacental antibodies till this age.
Objective: In infants born to unimmunized mothers, to
(i)serially measure the level of anti-measles antibodies from birth
to 9 months, (ii)study the pattern of decline, and (iii)identify pos-
sible factors that could predict lack of protection.
Methods & Materials: Institutional ethical clearance was
obtained. Written informed consent was taken from women
preparing to deliver babies in the hospital. Serum anti-measles
IgG was measured by quantitative ELISA in 61 consecutively born
infants at birth (cord blood from infant side), 14weeks (coin-
ciding with visit for EPI vaccination), 24 weeks (coinciding with
visit for third dose Hepatitis B vaccine) and 36weeks (just before
measles vaccination). Proportion of unprotected infants (antibody
titre <200 mIU/ml) was calculated at each time-point. Gesta-
tional age (preterm vs term), gestational weight (small-for-age vs
appropriate-for-age), initial antibody level at birth, were evaluated
as possible predictors.
Results:Anti-measles IgGantibody levels (±standarddeviation)
were 3235±169 IU/ml at birth, 994±127 IU/ml at 14weeks, 208±34
IU/ml at 24weeks, and 85±8 IU/ml at 36weeks (Figure 1A and 1B).
The proportion of unprotected infants was 0%, 11.5%, 72%, and 94%
respectively. Lack of protection did not correlate with premature
birth (odds ratio; 95% CI for preterm vs term was 0.90; 95%CI 0.26,
3.10 at 14weeks, and 0.40; 95%CI 0.04, 3.56 at 24weeks). Therewas
also no relationship to birth weight (odds ratio; 95% CI for SGA vs
AGA was 1.63; 0.33, 8.11 at 14 weeks and 0.86, 95%CI 0.26,2.78 at
24 weeks).
Conclusion:Majorityof infants lose transplacental anti-measles
antibodies between 14 and 24 weeks of age, and are susceptible to
measles. The lack of protection cannot be predicted by gestational
age or birth weight.
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The comparative analysis of the antibiotic
resistance proﬁle of fecal enterobacteria
isolated from medical students in Central and
Southeast Asia
I. Azizov ∗, D. Babenko, A. Lavrinenko, I. Belyaev,
K. Toleubekov
Karaganda State Medical University, Karaganda,
Kazakhstan
Background: The problem of antibiotic resistance spreading
has reached the global level requiring animmediate actions. One
of the possible way to spread out such microorganism is migra-
tion, including traveling due to foreign education. The aim of this
study is to analyze the antibiotic resistance of microorganisms by
Enterobacteriaceae family isolated from foreign medical students
(India, Pakistan) and medical students of Kazakhstan studying at
Karaganda State Medical University, Kazakhstan.
Methods & Materials: From November 2011 to October 2013,
403 stains were isolated from stool samples from foreign medical
students (India, Pakistan) and 109 isolates – from medical stu-
dents from Kazakhstan. Bacterial identiﬁcation was performed by
using MALDI-TOF (Microﬂex, Bruker). Antimicrobial susceptibility
testing has been carried out by disk diffusion and serial dilution
method according to EUCAST criteria. Statistical analysis was done
by WHONET 5.6 software.
Results: The antibiogrammof E. coli (as themost frequently iso-
lated microorganism) has shown higher level of resistance in the
cases of students from South-East Asia then Kazakhstan’s students
strains: for ampicillin (69.6% (95%CI, 63,9 - 74,7%) versus 33.3% (95%
CI, 17,95- 53,26%)), ceftazidime (59.5% (95% CI, 43.5-73.7%) versus
2.5% (95% CI, 0.5-12.9%), nalidixic acid (61.6% (95% CI, 56,6-66,4%)
versus 41.4% (95% CI, 30,6-53,1%). There was no difference in resis-
tance of E.coli, isolated from two groups (from India, Pakistan and
Kazakhstan) of the students for: ampicillin/sulbactam (6.3% and
5.3%, p = 0.945), cefuroxime (70% and 72.7%, p = 0.801), cefotaxime
(78.3%and61.1%, p =0.059), gentamycin (28.6%and9.5%, p =0.177),
ciproﬂoxacin (38.8% and 26.9%, p = 0.063). ESBL activity of E.coli
was detected at the same level in both groups (61% and 61.7%, p
= 0,997). There was no resistance to carbapemens (imipenem and
meropenem).
Conclusion: Our study of antibiotic resistance of the fecal iso-
lates from South-East and Central Asia students have shown the
same level of ESBL-producers and absence of resistance to car-
bapenems, in spite of fact that there are number of publications
about prevalence NDM-producing bacteria in Indian subcontinent.
At the same time, higher level of resistance for some-lactams and
quinolones was found in group of students from South-East Asia.
http://dx.doi.org/10.1016/j.ijid.2014.03.666
